Get started

MRNA

Moderna (MRNA) Swing Trade IdeaModerna broke trend to the downside, so long term view is more likely a short rather than long. As illustrated in the chart, I wouldn't short at current prices, but around the red level I have drawn. The trade is invalidated if it closes above the red zone with high volume. If it closes above it but on low volume, it could be a fake out with the following candles closing below it once again. The red zone at the very top is the next resistance zone if it does get through the first resistance zone. Please disregard the overall timeframe estimate, it can take longer or shorter for this trade to play out, but the move is the general idea.
NASDAQ:MRNAShort
by wallstreetnomad
3
MRNA OVERSOLD Entry on WOLFE WAVE 39min time-frameVery good risk and reward. MRNA dropped more than 40% last week and extended from the 6 day moving average which is at 316. There is a wolfe wave setup on the 39 min time frame. The projected target is calculated by extending a linear line between pivot 1 and 4 and projecting the line. This is represented as the green perforated line, as shown in the chart. The projected target is 354 which is expected to reach this price target within approx 39 hours (195 min x 12). However, in between 354 is the 6 day ma at 316. So most likely a mean reversion target is more likely to hit and anything above 316 should be bonus profits.
NASDAQ:MRNALong
by TOSOPTION
5
To the Moon or to the Ground ???In July-August 2021, one of the Wall Street Bets top rank plays was MRNA. Moderna did a great job in vaccine development, but that bullish move of +130% in 23 trading days was pure market manipulation! If you think that kind of move will happen again or not, the answer is: It depends on WSB..! I think a long Bearish-consolidation phase is ahead for Modern..! and it could go below 200..! Please check my previous Articles: Best, Moshkelgosha DISCLAIMER I’m not a certified financial planner/a certified financial analyst, an economist, a CPA, an accountant, or a lawyer. I’m not a finance professional through formal education. The contents on this site are for informational purposes only and do not constitute financial, accounting, or legal advice. I can’t promise that the information shared on my posts is appropriate for you or anyone else. By using this site, you agree to hold me harmless from any ramifications, financial or otherwise, that occur to you as a result of acting on information found on this site.
NASDAQ:MRNAShort
by Moshkelgosha
3
MRNA looks bearish with Aspen Trading Support & Resistance LevelAspen Trading S/R levels are showing resistance @ 345. MRNA has been trading choppy between a range and now it is at the top end of the range. It looks bearish in short-term. Please like, share and follow if you agree with the analysis. Note - Aspen Trading S/R levels are invite only. They can be accessed through my profile information. Disclaimer: This analysis is for information purpose only and does not constitute any investment advice.
MShort
by tradingswift
Novavax ShortPfizer's monopoly is very strong on the Covid-19 vaccines . They are spending millions hiding their side effects and creating hurdles for their competitors at the regulatory agencies SUCCESSFULLY . It maybe that Novavax has one the best products out there but that simply does not matter at this point , we know how powerful big pharma can be and Novavax's lateness to the game will not serve them well here . The biggest dangers to NVAX are now the regulatory agencies taking long/asking for additional info and the COVID-19 Antiviral drug news ( Merck's pill approval will be this months and Pfizer may come out with their Phase III study result any moment now). Both are very likely . NVAX will likely reject braking $200 TODAY. $195 -$200 will be a great entry point for a opening a short position on this . RISK /REWARD RATIO VERY LUCRATIVE .
NASDAQ:NVAXShort
by Bobpnmicro
4
Moderna sliding back to Earth. MRNAPivot on a huge impulse fractal confirmed. We are drawing more and more zigzags from now on. Our goals are shown. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NASDAQ:MRNAShort
by Rykin_Capital
Merck is Flying based on the biased perception..!Merck data shows Molnupiravir will decrease mortality and hospitalization which is a good news, but do not forget it does not mean you do not need COVID-19 Vaccine..! This is only for those who becomes positive for COVID test, while Vaccine is for everyone! While many people debate about their choice of being vaccinated or not, I would like to show other countries example: Australia: No Jab No Pay is an Australian policy initiative which withholds three state payments – Child Care Benefit, the Child Care Rebate and a portion of the fortnightly Family Tax Benefit part A per child – for parents of children under 20 years of age who are not fully immunized or on a recognized catch-up schedule. No Jab No Play is a related policy that disallows unvaccinated children from attending preschool and childcare centres, and imposes fines on childcare centres that admit unvaccinated children. The system allows exemptions for children who cannot be safely vaccinated for medical reasons. As a doctor I respect patients choice, but when it is about public health things will become a little complicated from ethical point of view! I got vaccinated as soon as it becomes possible, and asked all my family members to do so. I want to use this opportunity to ask you to get vaccinated and do not pay attention to misinformation. I published short analysis on MRNA before this news: Best, Moshkelgosha
NYSE:MRKShort
by Moshkelgosha
2
MRNA10.3.21 MRNA Bobby's Homework Assignment : MRNA is likely to find buyers in this general area. We missed the buying tail... but this is not a big deal. This was a difficult video for reasons that I explain in the video. It is very important to start using the drawing tools to get familiarity and learn the process of using those tools to read the market. Use the honeymoon period to get familiar with the tools. The honeymoon period is exciting, and you expect that there will be a learning curve, but your excitement can give you motivation. You expect the tools to be unfamiliar in the beginning, but if you tackle that aspect of your trading, it won't seem so bad with 30 days of effort. On the other hand, if you don't use that period of time with enthusiasm you may never achieve your goal.
NASDAQ:MRNA
by ScottBogatin
1